November 11, 2020
TRiNDS Genetic Confirmation Services
Many of the rare neuromuscular disorders we work with at TRiNDS have a genetic component. Some are caused by a variation in a gene or group of genes and others can be assigned subtypes by presence of certain variations. For a rare neuromuscular clinical trial, it’s essential to get these details right. Even among people with an eligible diagnosis, people with certain genotypes might not be amenable to an investigational product while others might be excluded from participation to reduce variation in the study. It is critical to confirm eligibility for a clinical trial consistently across sites and regions. It’s essential to record the genotype correctly across sites so trial analysis can explore possible effects of different genotypes on study results.
TRiNDS Genetic Confirmation offers central review of genetic testing results for rare neuromuscular disease trials. Our team of in – house licensed genetic counselors leverage past experience in Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), Pompe Disease, and other neuromuscular disorders. Our genetic counselors work with sponsors throughout trial planning and execution. Our team can help you design protocols, set up study procedures for central review, and collaborate with data management to properly capture the genetic data in your electronic data capture systems.
TRiNDS offers central expert genetic confirmation services to sponsors conducting clinical trials throughout the development process. We customize services to each project to meet its unique needs. Contact us for more about how TRiNDS can help your project succeed.
